Work

Efficacy and Safety of Xanomeline, a M1/M4 Receptor Preferencing Agonist, Plus Trospium, a Peripheral Muscarinic Antagonist, in Schizophrenia: Phase 2 Clinical Trial Results

Year: 2020

Type: article

Study design: Clinical Trial

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2020.02.446

Authors: Stephen Brannan, Sharon Sawchak, Andrew Miller, Steven M. Paul, Alan Breier

Institution: Indiana University School of Medicine

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3023112558

FWCI: 1.094

Cites:

Cited by: 7

Related to: 10